These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
768 related articles for article (PubMed ID: 3486598)
1. Dermatopathic lymphadenopathy. An immunophenotypic comparison of cases associated and unassociated with mycosis fungoides. Burke JS; Sheibani K; Rappaport H Am J Pathol; 1986 May; 123(2):256-63. PubMed ID: 3486598 [TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic differences between dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides. Weiss LM; Wood GS; Warnke RA Am J Pathol; 1985 Aug; 120(2):179-85. PubMed ID: 3161334 [TBL] [Abstract][Full Text] [Related]
3. Dermatopathic lymphadenopathy. Comparison of cases associated and unassociated with mycosis fungoides. Burke JS; Colby TV Am J Surg Pathol; 1981 Jun; 5(4):343-52. PubMed ID: 7270782 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical studies using monoclonal antibodies on lymph nodes from patients with mycosis fungoides and Sézary's syndrome. Willemze R; Scheffer E; Meijer CJ Am J Pathol; 1985 Jul; 120(1):46-54. PubMed ID: 3893151 [TBL] [Abstract][Full Text] [Related]
5. Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. Weiss LM; Hu E; Wood GS; Moulds C; Cleary ML; Warnke R; Sklar J N Engl J Med; 1985 Aug; 313(9):539-44. PubMed ID: 4022090 [TBL] [Abstract][Full Text] [Related]
6. Light microscopic, S-100 immunostaining, and ultrastructural analysis of dermatopathic lymphadenopathy, with and without associated mycosis fungoides. Herrera GA Am J Clin Pathol; 1987 Feb; 87(2):187-95. PubMed ID: 3544800 [TBL] [Abstract][Full Text] [Related]
7. Leu-8 and Leu-9 antigen phenotypes: immunologic criteria for the distinction of mycosis fungoides from cutaneous inflammation. Wood GS; Abel EA; Hoppe RT; Warnke RA J Am Acad Dermatol; 1986 Jun; 14(6):1006-13. PubMed ID: 3088069 [TBL] [Abstract][Full Text] [Related]
8. Coexisting Hodgkin's disease and mycosis fungoides. Immunohistochemical proof of its existence. Simrell CR; Boccia RV; Longo DL; Jaffe ES Arch Pathol Lab Med; 1986 Nov; 110(11):1029-34. PubMed ID: 3096258 [TBL] [Abstract][Full Text] [Related]
9. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies. Pai RK; Mullins FM; Kim YH; Kong CS Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522 [TBL] [Abstract][Full Text] [Related]
10. Dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides. Scheffer E; Meijer CJ; Van Vloten WA Cancer; 1980 Jan; 45(1):137-48. PubMed ID: 7350998 [TBL] [Abstract][Full Text] [Related]
11. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma. LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796 [TBL] [Abstract][Full Text] [Related]
12. Nuclear contour irregularity correlates with Leu-9-, Leu-8- cells in benign lymphoid infiltrates of skin. An ultrastructural morphometric and quantitative immunophenotypic analysis suggesting the normal T-cell counterpart to the malignant mycosis fungoides/Sézary cell. Payne CM; Spier CM; Grogan TM; Richter LC; Bjore CG; Cromey DW; Rangel CS Am J Dermatopathol; 1988 Oct; 10(5):377-89. PubMed ID: 3265861 [TBL] [Abstract][Full Text] [Related]
13. Clinical implication of dermatopathic lymphadenopathy among Japanese: a report of 19 cases. Kojima M; Nakamura S; Itoh H; Yamane Y; Shimizu K; Murayama K; Ohno Y; Tanaka H; Sugihara S; Suzuki Y; Shimano S; Masawa N Int J Surg Pathol; 2004 Apr; 12(2):127-32. PubMed ID: 15173917 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections. Izban KF; Hsi ED; Alkan S Mod Pathol; 1998 Oct; 11(10):978-82. PubMed ID: 9796726 [TBL] [Abstract][Full Text] [Related]
16. Dermatopathic lymphadenopathy a clinicopathologic analysis of lymph node biopsy over a fifteen-year period. Cooper RA; Dawson PJ; Rambo ON Calif Med; 1967 Mar; 106(3):170-5. PubMed ID: 5341844 [TBL] [Abstract][Full Text] [Related]
17. Lymphography in the assessment of mycosis fungoides. Tallroth K; Wiljasalo M; Valle M; Korhola O Lymphology; 1977 Sep; 10(3):147-50. PubMed ID: 592885 [TBL] [Abstract][Full Text] [Related]
18. Expression of Leu-8 antigen, a majority T-cell marker, is uncommon in mycosis fungoides. Abel EA; Wood GS; Hoppe RT; Warnke RA J Invest Dermatol; 1985 Sep; 85(3):199-202. PubMed ID: 3161956 [TBL] [Abstract][Full Text] [Related]
19. Expression of intercellular adhesion molecule 3 (CDw50) on endothelial cells in cutaneous lymphomas. A comparative study between nodal and cutaneous lymphomas. Dommann SN; Dommann-Scherrer CC; Ziegler T; Meyer J; Trüeb RM; Kündig T; Panizzon R; Burg G Am J Dermatopathol; 1997 Aug; 19(4):391-5. PubMed ID: 9261475 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic significance of clonal T-cell receptor beta gene rearrangements in lymph nodes of patients with mycosis fungoides. Bakels V; Van Oostveen JW; Geerts ML; Gordijn RL; Walboomers JM; Scheffer E; Meijer CJ; Willemze R J Pathol; 1993 Jul; 170(3):249-55. PubMed ID: 8133398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]